Omaha, NENCT06528301Now EnrollingIRB Ready

Lymphoma, B-Cell Clinical Trial in Omaha, NE

Access cutting-edge lymphoma, b-cell treatment through this clinical trial at a research site in Omaha. Study-provided care at no cost to qualified participants.

Sponsored by Umoja Biopharma

Quick Self-Assessment

See if you qualify for this Omaha location

Preparing your pre-screening questions…

Expert Care in Omaha

Access lymphoma, b-cell specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related lymphoma, b-cell treatment provided free

Apply for This Omaha Location

Check if you qualify for this lymphoma, b-cell clinical trial in Omaha, NE

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Omaha

    Convenient for NE residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Omaha site if eligible
  4. 4Begin participation

About This Lymphoma, B-Cell Study in Omaha

This study is a Phase 1 dose-escalation and dose-confirmation study to evaluate the safety and antitumor activity of UB-VV111. The study will enroll patients with relapsed/refractory large B-cell lymphoma (LBCL) and chronic lymphocytic leukemia (CLL).

Sponsor: Umoja Biopharma

Who Can Participate

Inclusion Criteria

18 years or older
Provides voluntary written informed consent
Relapsed or refractory large B-cell lymphoma (LBCL) or chronic lymphocytic leukemia (CLL)
Measurable disease according to Lugano 2014 criteria (LBCL) or iwCLL 2018 (CLL).
No serious concomitant diseases or active/uncontrolled infections
Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
Adequate organ function
Patients who have previously received CD19-directed therapy must have biopsy confirming CD19 expression following completion of prior CD19-directed therapy.

Exclusion Criteria

Women who are pregnant or breastfeeding
Current isolated central nervous system (CNS) involvement
Prior allogeneic bone marrow transplant, gene therapy, or adoptive cell transfer (exceptions include tumor-infiltrating lymphocytes and CAR T cells)
History of or active human immunodeficiency virus (HIV)
Active hepatitis B or C
Systemic immunodeficiency diseases, except for well-controlled Type I diabetes or thyroid disease
Ongoing CNS disease that would preclude neurologic assessment
Uncontrolled angina or other acute heart disease
Currently receiving treatment in another interventional clinical trial.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Omaha?

Yes, this clinical trial (NCT06528301) has an active research site in Omaha, NE that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Lymphoma, B-Cell Treatment Options in Omaha, NE

If you're searching for lymphoma, b-cell treatment options in Omaha, NE, this clinical trial (NCT06528301) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Omaha research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lymphoma, b-cell specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all lymphoma, b-cell clinical trials near you to find additional studies recruiting in your area.

More Lymphoma Trials in Omaha, NE

See all lymphoma clinical trials recruiting in Omaha — not just this study.

Browse Lymphoma Trials in Omaha →

Browse More Trials by Condition

Lymphoma TrialsPulmonary Hypertension TrialsAll Conditions →

Ready to Join in Omaha?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Omaha, NE